Featured Sessions

Dive into the insightful sessions from AllyGPO’s second annual Community Oncology Collective, held in Nashville, TN, in September 2025. This gallery features thought-provoking discussions led by oncology experts on topics ranging from innovative therapy integration to navigating healthcare policy impacts.

Opening Remarks

Get a front row seat to all the content at the Collective. See how Brian Ansay, AllyGPO’s CEO, kicked off the Collective.

Speaker

Brian Ansay, Chief Executive Officer, AllyGPO

OCSRI Experience

Hear leaders from Oklahoma Cancer Specialists and Research Institute (OCRSI) share their decision-making process, experience with AllyOncology, and perspectives on the future.

Speakers

Dr. Daron Street, MD President and CEO, Oklahoma Cancer Specialists & Research Institute; Advisory Board Member, MiBA Analytics

Max Thorsbakken, Chief Officer, Oklahoma Cancer Specialists & Research Institute

Tara Hallum, Chief Financial Officer, Oklahoma Cancer Specialists & Research Institute

Moderator: Aaron Denning, Chief Commercial Officer, AllyGPO

Intelligent Inventory: The Future Is Closer Than You Think

Oncology clinics are on the cusp of adopting smart, self-regulating inventory management systems that reduce administrative burden, improve cash flow, and allow more time for patient care. This talk will discuss the technology advances that are enabling automation of tedious ordering processes to precisely determine the drugs needed for upcoming treatments.

Speaker

Stuart McMahan, Chief Information Officer, AllyGPO

AI-Driven Clinical Analytics: Turning Complex Oncology Data into Actionable Insights

How do we better understand where patients sit in their complicated journey through cancer treatment? Discover how harmonizing data from multiple sources and applying the next generation of AI tools enables us to accurately and scalably answer questions about diagnoses, lines of therapy, drug utilization, adverse events, and outcomes.

Speaker

Scott Newman, SVP Life Sciences, MiBA Analytics

The Evolution of Drug Contracting

Despite their distinct challenges, pharmaceutical manufacturers, GPOs, and practices have a common interest in evolving drug contracts from volume-based terms to more targeted approaches that emphasize patient treatment and better outcomes. Learn how AI and data-driven analytics help uncover patterns in care, support more informed clinical decisions, and position community oncology practices to thrive in the next generation of contracting.

Speaker

Dr. Daron Street, MD President and CEO, Oklahoma Cancer Specialists & Research Institute; Advisory Board Member, MiBA Analytics

Minimizing Risks in a Buy-and-Bill Reimbursement Model

Explore the factors that influence payment collection in the buy-and-bill model and strategies to more effectively minimize your financial risks. Understand how payers set reimbursement rates, including ASP calculation. Learn how to spot problems that impact the revenue your practice needs to cover drug costs and to better estimate timing for receiving payments.

Speakers

Cass Schaedig, Principal, Willow Run Analytics

Building Trust in AI: Partnership, Not Replacement, in Cancer Care

Explore why most AI implementations fail in oncology practice and review a proven framework for building trustworthy AI systems that enhance rather than replace clinical judgment. Using real-world examples from cancer care, Dr. Parikh will discuss how well-designed AI can save weeks in diagnosis time, improve trial enrollment, and facilitate critical end-of-life conversations.

Speaker

Dr. Ravi B. Parikh, MD, MPP, FACP Director, Human-Algorithm Collaboration Lab at Emory University and Winship Cancer Institute

Realizing the Potential of Radiopharmaceutical Therapy in Community Oncology

As radiopharmaceutical use in cancer care grows significantly, now is the time for community practices to prepare. Learn what you can do today to build your foundation to serve as an important hub for theranostics — from building partnerships to participating in clinical trials.

Speaker

Dr. Dustin Boothe, MD Radiation Oncologist, Utah Cancer Specialists Director of Radiopharmaceutical Research, Intermountain Health

Content on this page (videos and downloadable slides) is provided for general informational and educational purposes only. Views and opinions are those of the speakers and do not necessarily reflect those of AllyGPO or any sponsor. This material is not medical, legal, regulatory, or purchasing advice and does not create a physician–patient, client, or other professional relationship. References to products, services, data, or technology—including demonstrations, performance descriptions, or forward-looking statements—are illustrative only, not endorsements, guarantees, or offers, and are subject to change. While accuracy is sought, information may be incomplete or out of date; please verify independently. AllyGPO makes no representations or warranties and disclaims liability for reliance. Third-party names and logos are the property of their respective owners. Except as permitted by law, you may not record, reproduce, distribute, publicly display, or create derivative works from this content without prior written permission from AllyGPO and the applicable speaker/author.